Challenges in managing dyspepsia in general practice

British Medical Journal

Volumn 315, Issue 7118, 1997, Pages 1284-1288

  Agréus, Lars ^a,c   Talley, Nicholas ^b  

^a UPPSALA UNIVERSITY   (Sweden)

^b UNIVERSITY OF SYDNEY   (Australia)

^c Råghusgatan G   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

HISTAMINE H2 RECEPTOR ANTAGONIST; NONSTEROID ANTIINFLAMMATORY AGENT; PROKINETIC AGENT;

ABDOMINAL PAIN; ARTICLE; BREATH ANALYSIS; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC ACCURACY; DYSPEPSIA; ENZYME LINKED IMMUNOSORBENT ASSAY; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL MOTILITY; GENERAL PRACTICE; HELICOBACTER PYLORI; HUMAN; NAUSEA; PEPTIC ULCER; PRIORITY JOURNAL;

EID: 0030664203     PISSN: 09598146     EISSN: None     Source Type: Journal    
DOI: 10.1136/bmj.315.7118.1284     Document Type: Article

References (40)

1. Colin-Jones D, Bloom B, Bodemar G, Crcan G, Freston J, Gugler R, et al. Management of dyspepsia: report of a working party. Lancet 1988;i:576-9.
2. Talley KJ, Colin-Jones D, Koch KJ, Koch M, Nyrén O, Stangliellini V. Functional dyspepsia: a classification with guidelines for diagnoses and management Gastroenterology Int 1991;4:145-60.
3. National Institutes of Health (NIH) Consensus Conference, Helicobacter pylori in peptic ulcer disease. JAMA 1991;272:65-9.
4. Whittaker MJ, Brun J, Carelli F. Controversy and consensus in the management of upper gastrointestinal disease in primary care. Int J Clin Pract 1997;51:239-43.
5. Talley NJ, Weaver AL, Tesmer DL, Zinsmeister AR. Lack of discriminant value of dyspepsia subgroups in patients referred for upper endoscopy. Gastroenterology 1993;105:1378-86.
6. Johannessen T, Petersen H, Kristensen P, Kleveland PM, Dybdahl J, Sandvik AK, et al. The intensity and variability of symptoms in dyspepsia. Scand J Prim Health Care 1993:11:50-5.
7. Bytzer P, Møller J, Hansen J, Schaffalitzky de Muckntell O. Symptom grouping in dyspepsia. Any predictive value? Scand J Gastronenterol 1993;28(suppl 197):28.
8. Lindell GH, Celebioglu F, Graffner HO. Non-ulcer dyspepsia in the long-term perspective. Eur J Gastroenterol Hepatol 1995;7:829-33.
9. Agréus I, Svärdsudd K, Nyrén O, Tibblin G. Irritable bowel syndrome and dyspepsia in the general population: overlap and lack of stability over time. Gastroenterology 1993;109:671-60.
10. Heading RC. Upper gastrointestinal symptoms in general practice: a multicenter UK study.J Drug Dev Clin Israel 1993;7:109-17.
11. Hansen JM, Bytzer P, Schaffalitzky de Muckadell OG. Placebo-controlled trial of cisapridc and nizaudine in unselected patients with non-ulcer dyspepsia. Gut 1994;34(suppl4)A9(34).
12. Tolley NJ, McNeil D, Piper DW. Discriminant value of dyspeptic symptoms: a study of ihc clinical presentation of 221 patients with dyspepsia of unknown cause, peptic ulceration, and cholelithiasis. Cut 1987;28:40-6.
13. Johannesscn T, Petcrsen II, Kleveland PM, Dybdahl JH, Sandvik AK, Brenna E, et al. The predictive value of history in dyspepsia. Scand J Gastrocjitcrul 1990;25:689-97.
14. Adang RP, Ambergen AW, Talmon JL, Hasman A, Vismans JF, Stockbrugger RW. The discriminative value of patient characteristics and dyspeptic symptoms for upper gastrointestinal endoscopie findings: a study on the clinical presentation of 1,147 patients. Digestion 199+;57:118-31.
15. Kang JY, Ho KY, Yeoh KG, Guan R. Chronic upper abdominal pain due lo duodenal ulcer and oilier and functional causes: its localization and nocturnal occurrence. J Gastroenterol Hepatol 1996;- 11:515-9.
16. Stanghellini V, Tosetti C, Paternicò A, Baibara G, Morselli-Labate AM, Monelti N, et al. Risk indicators of delayed gastric emptying of solids in patients with functional dyspepsia. Gastrocntcrotogy 1996;110:1036-42.
17. Bytzer P, Möller Hansen J, Havelund T, Malchow-Møller A. Schaflalitzky de Muckadell O. Pretlicting endoscopie diagnosis in the dyspeptic patient: the value of clinical judgement. Eur J Gastroenterol Hepatol 1996;8:359-63.
18. Hungin P. Open access gastroscopy [thesis]. Newcastle upon Tyne: University of Newcastle upon Tyne, 1996:pp112.
19. Carlsson R, Dent J, Glise H, Riley S, Torfgård K,Junghard O. E-aluauon of a questionnaire for the diagnosis of symptomatic gastroesophageal reflux disease (GERD). Gastroenterology 1996;110:A76.
20. Fass R, Fennerly MB, Yalam JM, Camargo L, Garewall H, Grade A, et al. Evaluation of the "omeprazolc test" in patients with typical symptoms of gastrocsopliagcal reflux disease. Gailmmlcrology 1997;112:A114.
21. Veldhuyzen van Zanten SJ, Clcary C, Tallcy NJ, I'etcrson TC, Nyren O, Bradley I.A. et ai. Drug treatment of functional dyspepsia: a systematic anal) sis of (rial methodology with recommendations for design of future trials. Am] Gaslnmilerol 1036;91:660-73.
22. Williams S, Weinman J, Dale J, Newman S. Patient expectations: what do primary care patients want from the OP and liow far does meeting expectations afreet patient satisfaction? Fam Pract 1993;12:193-201.
23. Lydeard S, Jones R. Factors aflecting the decision to consult with dyspepsia: comparison of consumers and non-consulters. J R Coll Gen Prart 1989:39:493-8.
24. 2-blockcr therapy or prompt cndoscopy in management of dyspepsia. Lancet 1991;343:811-6.
25. Hungin AP, Thomas PR, Bramble MG, Corbett WA, Idle X, Contractor BR, et al. What happens to patients following open access gastroscopy? An outcome study from general practice. Br J Cell Pract 1994;41:519-21.
26. British Society of Gastrocnterology. Dyspcpsia managment guidelines. London: BSG, 1996.
27. Patel P, Khulusi S, Mcndall MA, Lloyd RJazrawi U, Maxwell JD, et al. Prospective screening of dyspeptic patients by Helicobacter pylori serology. Lancet 1995:346:1315-8.
28. Kokkola A, Valle J, Haapiainen R, Sipponen P, Kivilaakso E, Poulakkainen P. Helicobacter pylori infection in young patients with gastric carcinoma. Scand J Gastroenterol 1996;31:643-7.
29. Lessen AT, Bytzer P, Schaffalitzky de Muckadel OB. H priori testing or prompt endoscopy for dyspeptic patients in primary care. A randomized control trial of two management strategies. Scand J Gastroenterol 1997;32(suppl 224):F93.
30. Loy CT, Irwig LM, Katelaris PI I.Talley NJ. Do commercial serological kits for I lelicobacter pylori infection ditfer in accuracy? A meta-analysis. Am J. Gastromlaol 1996;91:1138-44.
31. Enroili H, Rigo R, Hulten K, Engsirand U BM-test Helicobacter pylori for whole-blood samples: an easy and rapid detection method for II pylori infection. Cut 1996;2(suppl)A117.
32. Malferdieiner P, Mcgraud F, O'Morian C, Bell D, Bianchi Porro G, Deltenre M, et al. Current European concepts in the management of Helicobacter pylori infection-the Maastricht consensus report Eur J Gastroniterol Hepatol 1997;9:1-2.
33. Gilvarry J, Buckley MJM, Beattie S, Hamilton H, O'Morain CA. Eradication of Helicobacter pylori affects symptoms in non-ulcer dyspepsia. Scand J Gastroenterol 1997;32:535-40.
34. Agréus I, Engstrand L, Svärdsudd K, N'yrén O, Tibblin G. Helicobacter pylori scropositivity among Swedish adults with and without abdominal symptoms. A population-based epidemiological study. Scand J Gastroenterol 1995;30:752-7.
35. Sinha A, Trchorne C, Murray L, Williams DW, Dew MJ. Value of the Helisal test in screening dyspeptic patients for II pylori infection. Gut I997;40 (suppl 1):W7.
36. Mitchell HM, Lee A, Berkowicz J, Borody T. The use of serology to diagnose active Campylobacter pylori infection. MedJAusl 198S;149:601-9.
37. Sheu BS, Lin CY, Lin XZ, Shiesh SC, Yang HB, Chen CY. Long-term outcome of triple therapy in Helicobacter pylori-related non-ulcer dyspepsia: a prospective controlled assessment Am J Gastroniterol 1996;91:411-7.
38. Atherton JC, Spiller RC. The urea breath test for Helicobacter pylori. Gut 1994;35:723-5.
39. 14 urea for diagnosis of Helicobacter pylori infection. Scand J Gastroenterol 1995;30:1058-63.
40. McColl KE, el-Nujumi A, Murray L, el-Omar E, Gillen D, Dickson A, et al. The Hrlicobacter pylori breath test: a surrogate maiker for peptic ulcer disease in dyspeptic patients. Gut 1997;40:302-6.